(Q42675546)

English

Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

H Lynn Starr

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Jason Kemner

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of the National Medical Association

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

10 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

11S-16S

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics of attention deficit hyperactivity disorder in African American children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining clinically meaningful change in health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16350601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42675546&oldid=1578597965"